How does Celexa (citalopram) work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Celexa (Citalopram) Works

Celexa works by selectively blocking the reuptake of serotonin in the brain, which increases serotonin availability in the synaptic space and enhances serotonergic neurotransmission—this mechanism is responsible for its antidepressant effects. 1

Mechanism of Action

  • Citalopram potentiates serotonergic activity in the central nervous system by inhibiting neuronal reuptake of serotonin (5-HT), making it a highly selective serotonin reuptake inhibitor (SSRI). 1

  • The drug has minimal effects on norepinephrine and dopamine reuptake, distinguishing it from other antidepressants that affect multiple neurotransmitter systems. 1

  • Citalopram demonstrates very low affinity for other receptor systems including serotonin receptors (5-HT1A, 5-HT2A), dopamine receptors (D1, D2), adrenergic receptors (α1, α2, β), histamine H1 receptors, GABA receptors, muscarinic cholinergic receptors, and benzodiazepine receptors. 1

  • This high selectivity for serotonin reuptake inhibition, without significant binding to other receptors, explains why citalopram lacks the anticholinergic, sedative, and cardiovascular side effects commonly associated with tricyclic antidepressants. 1, 2

Pharmacological Selectivity

  • Citalopram is the most selective SSRI available, with a more specific pharmacological profile than other antidepressants in its class. 3, 4

  • The drug is a racemic mixture (50/50 split) of two enantiomers: S-citalopram (escitalopram) and R-citalopram. 1, 5

  • The S-enantiomer is primarily responsible for inhibiting serotonin reuptake, with an affinity for the serotonin transporter that is 30 to 40 times higher than the R-enantiomer. 5

  • Interestingly, the R-enantiomer can actually antagonize some of the therapeutic effects of the S-enantiomer by binding to an allosteric site on the serotonin transporter, which is why escitalopram (pure S-enantiomer) demonstrates superior efficacy compared to citalopram. 5

Clinical Implications of the Mechanism

  • Long-term treatment (14 days) in animal studies shows that tolerance to serotonin reuptake inhibition does not develop with citalopram. 1

  • In vitro studies demonstrate that citalopram is at least 8 times more potent than its metabolites (demethylcitalopram and didemethylcitalopram) in inhibiting serotonin reuptake, meaning the parent drug is responsible for the therapeutic effect. 1

  • The selective serotonergic mechanism makes citalopram effective not only for major depression but also for conditions involving serotonergic dysfunction, including anxiety disorders, panic disorder, obsessive-compulsive disorder, and premenstrual dysphoria. 6

Important Safety Consideration

  • While the serotonergic mechanism provides therapeutic benefit, citalopram has dose-dependent effects on cardiac conduction (QT prolongation) that are unrelated to its primary mechanism of action, necessitating maximum dose limits of 40 mg/day in adults under 60 and 20 mg/day in adults 60 and older. 7

Related Questions

What could be causing a 4-day symptom setback in a patient 7 weeks after increasing their citalopram (selective serotonin reuptake inhibitor) dose from 45mg to 52mg?
I've been taking citalopram (Citalopram Hydrobromide) 20 mg daily since my early twenties and want to switch to another antidepressant; how can I safely taper and which alternatives are appropriate?
Is a 10-year citalopram (Celexa) user experiencing an antidepressant 'poop-out' or instability due to rapid and successive dosage changes, given recent variable responses to adjustments from 45mg to 52mg to 60mg and back to 45mg, with worsening somber and dark thoughts at higher doses?
What is the best course of action for a 30-year-old patient with a 10-year history of taking cipramil (citalopram), who had a 95% effective response for 8 years, but experienced ups and downs after a significant life event 2 years ago, and has recently shown improvement in sleep, appetite, and ability to work, but had a negative reaction to a self-initiated dose increase from 52mg to 70mg?
Is it safe to reduce a patient's cipramil (citalopram) dose back to the initial increased dose of 7.5mg after only 10 days on the higher dose?
In a primigravida in labor who develops recurrent late decelerations with reduced variability after starting an oxytocin infusion, what is the appropriate management?
In an elderly female hospice patient with hypertension, atrial fibrillation, vascular dementia, prior transient ischemic attack, Crohn’s disease, diabetes, and anxiety who experienced a hypertensive urgency with blood pressure 220/74 mm Hg that fell to approximately 120/74 mm Hg after her usual dose of oral amlodipine, what are the appropriate next management steps?
Which of the following applies to amyloidosis: a) cardiac amyloidosis often presents with arrhythmias, b) renal involvement mainly causes microscopic hematuria, c) subcutaneous (fat‑pad) aspiration biopsy is the safest diagnostic method, d) it can develop as a complication of long‑term chronic hemodialysis, e) dapsone is the treatment of choice?
In an elderly hospice patient with vascular dementia and prior transient ischemic attack who is on oral amlodipine and now has a blood pressure of 203/74 mm Hg without symptoms of end‑organ damage, what are the appropriate next steps in management?
How is the Bentall procedure performed?
In a 50‑year‑old man with hypertension on chlorthalidone 50 mg daily, losartan 100 mg daily, amlodipine 10 mg daily, and metoprolol 100 mg daily whose blood pressure remains 140/90 mm Hg, what is the next best step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.